in4thelonghaul

10 Biotechs in Stem Cells that Could Profit Under the Democrats

Other criteria one should consider before investing in these companies is cash on hand to burn rate, and patents...most stem cell plays are on very shaky financial footings. GERN is an exception, they are well funded. GERN's sh/pr has recently taken a 20% hit due to the FDA placing a clinical hold on its experimental treatment for spinal injury. The stock has recovered a bit from already, but likely will regain the $5.00 level when the FDA comes to its senses or Bush is booted out of office. Expect McCain to be as, or nearly as favorably disposed towards stem cell research as the Democrats...he isn't exactly beholden to or a champion of the views held by the religious right. GERN has a rather large collection of patents holdings as well...I suspect BP would like to acquire these on the cheap. Jan. calls on GERN are my bet.